Search results
Scientists develop novel antibody treatment for kidney cancer
Medical Xpress· 4 hours agoAntibody therapies called bispecific T cell engagers (BTEs) have emerged as effective treatments for some blood cancers but have been more difficult to ...
New study highlights potential of covalent radioligands in cancer treatment
Medical Xpress· 6 hours agoThe study provides a hopeful perspective on treating metastatic cancer, which is responsible for the majority of deaths from all cancers. In 2020, the Journal ...
Test to detect if breast cancer will return ‘100 per cent accurate’
The Telegraph via Yahoo News· 3 days agoColoured scanning electron micrograph of a breast cancer cell, showing its uneven surface and...
NIH scientists develop AI tool to predict how cancer patients will respond to immunotherapy
KSAN - KLST San Angelo· 21 hours agoWhat: In a proof-of-concept study, researchers at the National Institutes of Health (NIH) have developed an artificial intelligence (AI) tool that uses routine clinical data, such as that from ...
Molecular switch linked to lineage plasticity, the | Newswise
Newswise· 16 hours agoTwo genes working in tandem play a critical role in shaping the identity and behavior of prostate ...
Common types of skin cancer explained
Medical Xpress· 4 days agoSkin cancer is the most common cancer in the U.S., affecting millions worldwide. This cancer comes in two main types: melanoma, which ...
NIH AI tool predicts cancer patients’ immunotherapy outcomes
Pharmaceutical Technology via Yahoo Finance· 12 hours agoThe tool can predict the response to immune checkpoint inhibitors for cancer patients. According to...
Weight-loss injections could halve risk of cancer
The Telegraph via Yahoo News· 3 hours agoSemaglutide Ozempic injections could cut the risk of obesity-related cancers - imyskin/iStockphoto Weight-loss jabs like Ozempic could cut the risk of ...
Leukemia drug passes final trial phase with flying colors
Medical Xpress· 35 minutes agoAsciminib, is known by the brand name Scemblix, produced by Swiss-based, Novartis Pharma AG. It...
Understanding CAR T-cell therapy: A conversation with Northside’s Dr. Melhem Solh - Atlanta Business...
The Business Journals· 1 day agoDr. Melhem Solh, medical director of the cellular therapy program at Northside Hospital, answers...
